Global Chronic Disease Management Market reached US$ 4.8 billion in 2022 and is expected to reach US$ 14.6 billion by 2031, growing with a CAGR of 11.4% during the forecast period 2024-2031.
Chronic disease management refers to the continuous care and support provided to individuals with long-term health conditions, such as diabetes, heart disease, asthma, and arthritis. It involves a combination of medical treatments, lifestyle modifications, and patient education aimed at improving quality of life, preventing complications, and managing symptoms effectively.
Managing chronic diseases requires a long-term approach, as these conditions often persist for years or even a lifetime. Effective chronic disease management focuses on regular monitoring, personalized care plans, and proactive interventions. This can include medication management, physical therapy, nutrition counseling, and mental health support. The goal is not only to alleviate symptoms but also to prevent further deterioration and improve overall health outcomes. As chronic diseases continue to rise globally, especially with aging populations, managing these conditions has become a critical focus in healthcare, emphasizing the importance of integrated care across different medical specialties.
Download Free Sample PDF: https://www.datamintelligence.com/download-sample/chronic-disease-management-market
Market Growth Drivers:
Technological Advancements
In October 2022, Sweetch, a leader in Digital Therapeutics, launched a precision engagement platform for managing chronic illnesses. The platform was updated to enhance patient compliance, addressing a critical issue. Non-compliance with treatment plans and behavior changes in chronic condition patients contributes to immense human suffering and costs the healthcare system hundreds of billions of dollars annually. Even the best therapies require consistent, personalized interventions that extend beyond hospitals and clinics, engaging patients in their everyday lives to drive better clinical outcomes.
Active Major Players in Chronic Disease Management Solutions
In January 2023, Valencell introduced its first chronic disease management solution, designed to help patients with hypertension monitor their blood pressure more effectively and maintain consistent treatment adherence. This innovative device offers a comfortable, cuff-free experience, taking a reading in under a minute using a small probe placed on the middle finger. The device leverages photoplethysmography (PPG) sensors to measure blood flow patterns by detecting reflected light, providing a quick and non-invasive way to track blood pressure.
Market Segments:
- By Type: Solution, Services
- By Service Type: Consulting Service, Implementation Service, Educational Service, Others
- By Delivery Mode: On-Premise Solution, Cloud-Based Solution, Web-Based
- By Indication: Cardiovascular Diseases (CVD), Diabetes, Chronic Obstructive Pulmonary Disorders (COPD), Arthritis, Asthma, Cancer, Others
- By End-user: Healthcare Providers, Healthcare Payers, Others
- By Region: North America, Latin America, Europe, Asia Pacific, Middle East and Africa
Top Key Players:
- Allscripts Healthcare Solutions Inc.
- TriZetto Corporation
- Siemens Healthcare Private Limited
- IBM
- Pegasystems Inc.
- Koninklijke Philips NV
- EXL Healthcare
- Infosys Limited
- ScienceSoft USA Corporation
- ZeOmega
Customize Your Scope: https://www.datamintelligence.com/customize/chronic-disease-management-market
Regional Growth
Chronic Disease Prevalence, Rising Awareness, and Advanced Healthcare Infrastructure
North America continues to lead the global chronic disease management market, with chronic conditions like diabetes, cancer, heart disease, and stroke affecting six out of ten Americans. These diseases not only contribute significantly to healthcare costs but are also the leading causes of death and disability in the United States.
According to the Centers for Disease Control and Prevention (CDC), over 37 million Americans have diabetes, with 90-95% of them living with type 2 diabetes. This chronic condition can lead to immune, neurological, and cardiovascular complications, severely impacting quality of life. Additionally, the American Diabetes Association estimates that diabetes accounts for one in every seven healthcare dollars spent in the U.S.
A study by Johns Hopkins and Corrie Health found that digital health interventions led to a 50% reduction in the 30-day readmission rate for patients who experienced an acute myocardial infarction (AMI), showing the potential of digital solutions in improving chronic disease management and patient outcomes.
Key Development
In March 2023, Royal Philips, a leader in health technology, introduced Philips Virtual Care Management, a versatile suite of solutions and services. Designed to reduce emergency room visits and lower care costs, this innovative platform enhances chronic disease management, ultimately easing the workload on hospital staff and improving overall healthcare efficiency.
